202 related articles for article (PubMed ID: 38815775)
1. Nanomaterial in controlling biofilms and virulence of microbial pathogens.
Tungare K; Gupta J; Bhori M; Garse S; Kadam A; Jha P; Jobby R; Amanullah M; Vijayakumar S
Microb Pathog; 2024 Jul; 192():106722. PubMed ID: 38815775
[TBL] [Abstract][Full Text] [Related]
2. Prevention of microbial biofilms - the contribution of micro and nanostructured materials.
Grumezescu AM; Chifiriuc CM
Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506
[TBL] [Abstract][Full Text] [Related]
3. Control of biofilm-associated infections by signaling molecules and nanoparticles.
Holban AM; Gestal MC; Grumezescu AM
Int J Pharm; 2016 Aug; 510(2):409-18. PubMed ID: 26945736
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology for Targeted Detection and Removal of Bacteria: Opportunities and Challenges.
Hajipour MJ; Saei AA; Walker ED; Conley B; Omidi Y; Lee KB; Mahmoudi M
Adv Sci (Weinh); 2021 Nov; 8(21):e2100556. PubMed ID: 34558234
[TBL] [Abstract][Full Text] [Related]
5. Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the Nanoscale.
Himanshu ; Mukherjee R; Vidic J; Leal E; da Costa AC; Prudencio CR; Raj VS; Chang CM; Pandey RP
Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627247
[TBL] [Abstract][Full Text] [Related]
6. Nanomaterials for alternative antibacterial therapy.
Hemeg HA
Int J Nanomedicine; 2017; 12():8211-8225. PubMed ID: 29184409
[TBL] [Abstract][Full Text] [Related]
7. Pillar[
Jothi Nayaki S; Roja A; Ravindhiran R; Sivarajan K; Arunachalam M; Dhandapani K
ACS Infect Dis; 2024 Apr; 10(4):1080-1096. PubMed ID: 38546344
[TBL] [Abstract][Full Text] [Related]
8. Nanomaterials as Promising Alternative in the Infection Treatment.
Vallet-Regí M; González B; Izquierdo-Barba I
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31382674
[TBL] [Abstract][Full Text] [Related]
9. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections.
Makabenta JMV; Nabawy A; Li CH; Schmidt-Malan S; Patel R; Rotello VM
Nat Rev Microbiol; 2021 Jan; 19(1):23-36. PubMed ID: 32814862
[TBL] [Abstract][Full Text] [Related]
10. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
Subhaswaraj P; Syed A; Siddhardha B
Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance and Nanotechnology: A narrative review.
Zhu X; Tang Q; Zhou X; Momeni MR
Microb Pathog; 2024 Jun; ():106741. PubMed ID: 38871198
[TBL] [Abstract][Full Text] [Related]
12. Quantum dots: a next generation approach for pathogenic microbial biofilm inhibition; mechanistic insights, existing challenges, and future potential.
Koul K; Jawanda IK; Soni T; Singh P; Sharma D; Kumari S
Arch Microbiol; 2024 Mar; 206(4):158. PubMed ID: 38480540
[TBL] [Abstract][Full Text] [Related]
13. Metal and Metal Oxide Nanoparticle as a Novel Antibiotic Carrier for the Direct Delivery of Antibiotics.
Kotrange H; Najda A; Bains A; Gruszecki R; Chawla P; Tosif MM
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502504
[TBL] [Abstract][Full Text] [Related]
14. Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.
Dos Santos Ramos MA; Da Silva PB; Spósito L; De Toledo LG; Bonifácio BV; Rodero CF; Dos Santos KC; Chorilli M; Bauab TM
Int J Nanomedicine; 2018; 13():1179-1213. PubMed ID: 29520143
[TBL] [Abstract][Full Text] [Related]
15. Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic: adaptation phenomena and cross-resistance.
Mann R; Holmes A; McNeilly O; Cavaliere R; Sotiriou GA; Rice SA; Gunawan C
J Nanobiotechnology; 2021 Sep; 19(1):291. PubMed ID: 34579731
[TBL] [Abstract][Full Text] [Related]
16. Green synthesized silver nanoparticles from Phoenix dactylifera synergistically interact with bioactive extract of Punica granatum against bacterial virulence and biofilm development.
Samreen ; Ahmad I; Khan SA; Naseer A; Nazir A
Microb Pathog; 2024 Jul; 192():106708. PubMed ID: 38782213
[TBL] [Abstract][Full Text] [Related]
17. Molecular Aspects of the Functioning of Pathogenic Bacteria Biofilm Based on
Juszczuk-Kubiak E
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473900
[TBL] [Abstract][Full Text] [Related]
18. The interplay of Pseudomonas aeruginosa and Staphylococcus aureus in dual-species biofilms impacts development, antibiotic resistance and virulence of biofilms in in vitro wound infection models.
Vestweber PK; Wächter J; Planz V; Jung N; Windbergs M
PLoS One; 2024; 19(5):e0304491. PubMed ID: 38805522
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects.
Mba IE; Nweze EI
World J Microbiol Biotechnol; 2021 May; 37(6):108. PubMed ID: 34046779
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal, quorum quenching and anti-biofilm nanofactories: a new niche for nanotechnologists.
Singh BN; Prateeksha ; Upreti DK; Singh BR; Defoirdt T; Gupta VK; De Souza AO; Singh HB; Barreira JC; Ferreira IC; Vahabi K
Crit Rev Biotechnol; 2017 Jun; 37(4):525-540. PubMed ID: 27684212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
